$NUMD
Nu-Med Plus Inc

2022 Q1 Form 10-K Financial Statement

#000154812322000038 Filed on March 31, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $57.64K $109.7K $830.1K
YoY Change -83.72% -77.55% -58.14%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.020K $2.650K $9.365K
YoY Change -23.77% 0.0% -20.6%
% of Gross Profit
Operating Expenses $59.65K $112.3K $839.4K
YoY Change -83.28% -77.13% -57.92%
Operating Profit -$59.65K -$839.4K
YoY Change -57.92%
Interest Expense $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $3.000K
YoY Change
Pretax Income -$56.65K -$112.3K $215.8K
YoY Change -84.12% -77.23% -58.68%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$56.65K -$112.3K -$830.1K
YoY Change -84.12% -77.23% -58.68%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share -$713.90 -$2.023K -$0.01
COMMON SHARES
Basic Shares Outstanding 79.35M shares 79.35M shares 73.37M shares
Diluted Shares Outstanding 79.35M shares 73.37M shares

Balance Sheet

Concept 2022 Q1 2021 Q4 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.540K $11.68K $11.68K
YoY Change -98.18% -93.8% -93.8%
Cash & Equivalents $2.537K
Short-Term Investments
Other Short-Term Assets $5.140K $0.00 $0.00
YoY Change -96.1% -100.0% -100.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $7.680K $11.68K $11.68K
YoY Change -97.17% -97.83% -97.83%
LONG-TERM ASSETS
Property, Plant & Equipment $250.00 $2.266K $10.49K
YoY Change -98.21% -80.52% -46.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $250.00 $10.49K $10.48K
YoY Change -98.21% -46.52% -46.59%
TOTAL ASSETS
Total Short-Term Assets $7.680K $11.68K $11.68K
Total Long-Term Assets $250.00 $10.49K $10.48K
Total Assets $7.930K $22.16K $22.16K
YoY Change -97.22% -96.02% -96.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $78.24K $27.74K $53.74K
YoY Change 102.43% 6.51% 16.7%
Accrued Expenses $118.7K $92.56K $100.8K
YoY Change 157.85% 255.72% 196.41%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $196.9K $154.5K $154.5K
YoY Change 132.6% 93.04% 93.03%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $196.9K $154.5K $154.5K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $196.9K $154.5K $154.5K
YoY Change 109.38% 72.78% 72.78%
SHAREHOLDERS EQUITY
Retained Earnings -$9.569M
YoY Change 9.5%
Common Stock $79.35K
YoY Change 55.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$189.0K -$132.4K -$132.4K
YoY Change
Total Liabilities & Shareholders Equity $7.930K $22.16K $22.16K
YoY Change -97.22% -96.02% -96.02%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021
OPERATING ACTIVITIES
Net Income -$56.65K -$112.3K -$830.1K
YoY Change -84.12% -77.23% -58.68%
Depreciation, Depletion And Amortization $2.020K $2.650K $9.365K
YoY Change -23.77% 0.0% -20.6%
Cash From Operating Activities -$12.14K -$20.16K -$206.8K
YoY Change -84.68% -71.71% -50.14%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $3.000K
YoY Change
Cash From Investing Activities $3.000K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $30.00K
YoY Change -85.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 $30.00K
YoY Change -100.0% -100.0% -94.97%
NET CHANGE
Cash From Operating Activities -12.14K -20.16K -$206.8K
Cash From Investing Activities 3.000K
Cash From Financing Activities 0.000 0.000 $30.00K
Net Change In Cash -9.140K -20.16K -$176.8K
YoY Change -81.44% -112.84% -197.47%
FREE CASH FLOW
Cash From Operating Activities -$12.14K -$20.16K -$206.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001543637
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
000-54808
CY2021 dei Entity Registrant Name
EntityRegistrantName
NU-MED PLUS, INC.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-3672530
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
455 East 500 South, Suite 203
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Salt Lake City
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84111
CY2021 dei City Area Code
CityAreaCode
801
CY2021 dei Local Phone Number
LocalPhoneNumber
746-3570
CY2021 dei Security12b Title
Security12bTitle
None
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
4992517 USD
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
79348469 shares
CY2021 dei Auditor Firm
AuditorFirmId
3627
CY2021 dei Auditor Name
AuditorName
Sadler, Gibb & Associates, LLC
CY2021 dei Auditor Location
AuditorLocation
Draper, UT
CY2021Q4 us-gaap Cash
Cash
11675 USD
CY2020Q4 us-gaap Cash
Cash
188506 USD
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11631 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
349017 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
11675 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
537523 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2266 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8222 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7981 USD
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
10488 USD
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
19612 USD
CY2021Q4 us-gaap Assets
Assets
22163 USD
CY2020Q4 us-gaap Assets
Assets
557135 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
27744 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
26048 USD
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
26000 USD
CY2020Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
20000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
92555 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26019 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
8222 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
7981 USD
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
USD
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
154521 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
80048 USD
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
USD
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
9384 USD
CY2021Q4 us-gaap Liabilities
Liabilities
154521 USD
CY2020Q4 us-gaap Liabilities
Liabilities
89432 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
79348469 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79348469 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51028469 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51028469 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
79349 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
51029 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9357587 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8431593 USD
CY2021Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
USD
CY2020Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
724314 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9569294 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8739233 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-132358 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
467703 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22163 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
557135 USD
CY2021 us-gaap Revenues
Revenues
USD
CY2020 us-gaap Revenues
Revenues
USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32283 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
58261 USD
CY2021 us-gaap Salaries And Wages
SalariesAndWages
267458 USD
CY2020 us-gaap Salaries And Wages
SalariesAndWages
706256 USD
CY2021 numd Operating Lease Rent Expense
OperatingLeaseRentExpense
23040 USD
CY2020 numd Operating Lease Rent Expense
OperatingLeaseRentExpense
18757 USD
CY2021 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
507299 USD
CY2020 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
1199609 USD
CY2021 us-gaap Depreciation
Depreciation
9365 USD
CY2020 us-gaap Depreciation
Depreciation
11794 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
839445 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
1994677 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-839445 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-1994677 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
9384 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
USD
CY2021 us-gaap Interest Expense
InterestExpense
USD
CY2020 us-gaap Interest Expense
InterestExpense
14322 USD
CY2021 us-gaap Other Income
OtherIncome
9384 USD
CY2020 us-gaap Other Income
OtherIncome
-14322 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-830061 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-2008999 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-830061 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-2008999 USD
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
73374113 shares
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54514524 shares
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-370432 USD
CY2020 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
940500 USD
CY2020 numd Stock Subscription Payable Cash
StockSubscriptionPayableCash
386842 USD
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
200000 USD
CY2020 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
348642 USD
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
10000 USD
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
200000 USD
CY2020 numd Stock Issued For Compensation
StockIssuedForCompensation
561150 USD
CY2020 numd Stock To Be Issued For Service
StockToBeIssuedForService
200000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-2008999 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
467703 USD
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
30000 USD
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
200000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-830061 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-132358 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-830061 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-2008999 USD
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9365 USD
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11794 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
9384 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
200000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
961150 USD
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
12011 USD
CY2020 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
12349 USD
CY2021 numd Amortization Of Prepaid Consulting
AmortizationOfPrepaidConsulting
USD
CY2020 numd Amortization Of Prepaid Consulting
AmortizationOfPrepaidConsulting
596441 USD
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-349017 USD
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1921 USD
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-12011 USD
CY2020 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-12349 USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
27696 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-13772 USD
CY2021 us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
-20000 USD
CY2020 us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
5915 USD
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
66536 USD
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
30751 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-206831 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-414799 USD
CY2021 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
USD
CY2020 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
386842 USD
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
USD
CY2020 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
9384 USD
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
30000 USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
200000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
596226 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-176831 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
181427 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
188506 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7079 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
188506 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
1175 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
1175 USD
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
CY2021 us-gaap Stock Issued1
StockIssued1
USD
CY2020 us-gaap Stock Issued1
StockIssued1
676711 USD
CY2021 numd Conversion Of Accrued Interest For Common Stock
ConversionOfAccruedInterestForCommonStock
USD
CY2020 numd Conversion Of Accrued Interest For Common Stock
ConversionOfAccruedInterestForCommonStock
358642 USD
CY2021 numd Common Stock Issued For Prepaid Services
CommonStockIssuedForPrepaidServices
USD
CY2020 numd Common Stock Issued For Prepaid Services
CommonStockIssuedForPrepaidServices
940500 USD
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
USD
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
11934 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:10pt; margin-bottom:0pt; "> b. Estimates </p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:10pt; margin-bottom:0pt; ">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p>
CY2020Q1 numd Hanover Compensation Monthly Payment
HanoverCompensationMonthlyPayment
3500 USD
CY2020Q1 numd Hanover Total Compensation Shares
HanoverTotalCompensationShares
750000 shares
CY2020Q1 numd Hanover Tranche Compensation Shares
HanoverTrancheCompensationShares
187500 shares
CY2020 numd Hanover Total Compensation Shares
HanoverTotalCompensationShares
750000 shares
CY2020 numd Hanover Price Per Share
HanoverPricePerShare
0.50
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-830061 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-2008999 USD
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73374113 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54514524 shares
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73374113 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54514524 shares
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2021 numd Dilutive Shares
DilutiveShares
0 shares
CY2020 numd Dilutive Shares
DilutiveShares
0 shares
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:10pt; margin-bottom:0pt; "> g. Concentrations and Credit Risk </p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:10pt; margin-bottom:0pt; ">The Company has relied on a small group of investors to fund its operations. If this group becomes unable or unwilling to provide additional funding, the Company may be unable to remain in business or to execute on its business plan. </p>
CY2021 numd Planned Expenditures
PlannedExpenditures
1250000 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
90368 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
90368 USD
CY2021Q4 numd Accumulated Depreciation
AccumulatedDepreciation
88102 USD
CY2020Q4 numd Accumulated Depreciation
AccumulatedDepreciation
78737 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2266 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11631 USD
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9365 USD
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11794 USD
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
0 USD
CY2020Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
724314 USD
CY2021 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
0 shares
CY2020 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
28902688 shares
CY2020Q2 numd Merrell Stock Compensation
MerrellStockCompensation
500000 shares
CY2020Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
500000 shares
CY2020Q2 numd Merrell Stock Compensation Value
MerrellStockCompensationValue
500000 USD
CY2021 numd Merrell Stock Compensation
MerrellStockCompensation
2000000 shares
CY2020 numd Gill Shares Received In Consulting Agreement
GillSharesReceivedInConsultingAgreement
500000 shares
CY2021 numd Waterside Capital Adviserincentiveshares
WatersideCapitalAdviserincentiveshares
2000000 shares
CY2021 numd Waterside Capital Advisersharevalue
WatersideCapitalAdvisersharevalue
200000 USD
CY2020 numd Hanover Total Value
HanoverTotalValue
375000 USD
CY2020 numd Hanover Amount Expensed
HanoverAmountExpensed
298973 USD
CY2020 numd Hanover Amount To Be Expensed
HanoverAmountToBeExpensed
76027 USD
CY2020 numd Gill Shares Received In Consulting Agreement
GillSharesReceivedInConsultingAgreement
500000 shares
CY2020 numd Kristensen Shares Received In Consulting Agreement
KristensenSharesReceivedInConsultingAgreement
100000 shares
CY2020 numd Gill And Kristensen Consulting Shares Value Total
GillAndKristensenConsultingSharesValueTotal
565500 USD
CY2020 numd Gill And Kristensen Consulting Shares Amount Amortized
GillAndKristensenConsultingSharesAmountAmortized
299391 USD
CY2020 numd Gill And Kristensen Consulting Shares Amount Remaining
GillAndKristensenConsultingSharesAmountRemaining
266109 USD
CY2020Q3 numd Waterside Capital Advisersigningshares
WatersideCapitalAdvisersigningshares
50000 shares
CY2020Q3 numd Waterside Capital Adviser30dayshares
WatersideCapitalAdviser30dayshares
75000 shares
CY2020Q3 numd Waterside Capital Adviser60dayshares
WatersideCapitalAdviser60dayshares
75000 shares
CY2020 numd Waterside Capital Advisersharevalue
WatersideCapitalAdvisersharevalue
200000 USD
CY2020Q3 numd Waterside Capital Adviserincentiveshares
WatersideCapitalAdviserincentiveshares
2000000 shares
CY2017Q1 numd Monthly Office Lease Payment
MonthlyOfficeLeasePayment
950 USD
numd Monthly Office Lease Payment
MonthlyOfficeLeasePayment
978 USD
numd Monthly Office Lease Payment
MonthlyOfficeLeasePayment
1008 USD
numd Monthly Office Lease Payment
MonthlyOfficeLeasePayment
1038 USD
numd Monthly Office Lease Payment
MonthlyOfficeLeasePayment
1038 USD
CY2021Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
8471 USD
CY2021Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
USD
CY2021Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
USD
CY2021 numd Monthly Office Lease Payment
MonthlyOfficeLeasePayment
1050 USD
CY2020Q4 numd Contributed Services Officer
ContributedServicesOfficer
635000 USD
CY2019Q4 numd Contributed Services Officer
ContributedServicesOfficer
200000 USD
CY2020Q4 numd Scs Total Payable
ScsTotalPayable
524314 USD
CY2020Q4 numd Scs Total Settlement Shares
ScsTotalSettlementShares
28000000 shares
CY2021Q1 numd Scs Total Settlement Shares
ScsTotalSettlementShares
28000000 shares
CY2021Q4 numd Scs Convertible Promissory Note Principal
ScsConvertiblePromissoryNotePrincipal
100000 USD
CY2021Q4 numd Scs Convertible Promissory Note Interest Rate
ScsConvertiblePromissoryNoteInterestRate
0.055 pure
CY2021Q4 numd Scs Convertible Promissory Note Conversion Price
ScsConvertiblePromissoryNoteConversionPrice
0.01
CY2020Q4 numd Scs Convertible Promissory Note Interest Accrued
ScsConvertiblePromissoryNoteInterestAccrued
61274 USD
CY2021 numd Convertible Promissory Note Interest Rate
ConvertiblePromissoryNoteInterestRate
0.08 pure
CY2021 numd Convertible Promissory Note Conversion Price
ConvertiblePromissoryNoteConversionPrice
0.01
CY2020Q4 numd Convertible Promissory Note Accrued Interest
ConvertiblePromissoryNoteAccruedInterest
60953 USD
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
230100 USD
CY2020Q4 numd Scs Convertible Promissory Note Interest Accrued Total
ScsConvertiblePromissoryNoteInterestAccruedTotal
118542 USD
CY2020Q4 numd Scs Convertible Promissory Note Conversion Price
ScsConvertiblePromissoryNoteConversionPrice
0.01
CY2020Q4 numd Scs Subscription Payable
ScsSubscriptionPayable
175672 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
215816 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
522340 USD
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Depreciation
IncomeTaxReconciliationNondeductibleExpenseDepreciation
2435 USD
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Depreciation
IncomeTaxReconciliationNondeductibleExpenseDepreciation
3066 USD
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
52000 USD
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
165100 USD
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
USD
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
USD
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Amortization
IncomeTaxReconciliationNondeductibleExpenseAmortization
USD
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Amortization
IncomeTaxReconciliationNondeductibleExpenseAmortization
USD
CY2021 numd Income Tax Reconciliation Nondeductible Expense Gain Loss On Derivative
IncomeTaxReconciliationNondeductibleExpenseGainLossOnDerivative
USD
CY2020 numd Income Tax Reconciliation Nondeductible Expense Gain Loss On Derivative
IncomeTaxReconciliationNondeductibleExpenseGainLossOnDerivative
USD
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
161381 USD
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
354174 USD
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
USD
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2082668 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1921462 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
9635 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
11794 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2073033 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1909668 USD
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
USD
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
14346579 USD

Files In Submission

Name View Source Status
0001548123-22-000038-index-headers.html Edgar Link pending
0001548123-22-000038-index.html Edgar Link pending
0001548123-22-000038.txt Edgar Link pending
0001548123-22-000038-xbrl.zip Edgar Link pending
ex311.htm Edgar Link pending
ex312.htm Edgar Link pending
ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
numd-20211231.xsd Edgar Link pending
numd-20211231_cal.xml Edgar Link unprocessable
numd-20211231_def.xml Edgar Link unprocessable
numd-20211231_lab.xml Edgar Link unprocessable
numd-20211231_pre.xml Edgar Link unprocessable
numd10k1221.htm Edgar Link pending
numd10k1221_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending